OH2 Oncolytic Viral Therapy in Pancreatic Cancer

Clinical trial NCT04637698 · TERMINATED

Trial details

NCT number: NCT04637698
Sponsor: Binhui Biopharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2021-02-02
Primary completion: 2023-05-04
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.